Renaissance Capital logo

GKOS News

June 2015 was the most active month for IPOs since the Dotcom Bubble

June 2015 saw 35 initial public offerings, more than any month since August 2000, when 66 companies went public. Since then, there have now been just nine months with over 30 IPOs, including six in the past two years. The 35 June IPOs raised $5.9 billion, more than the $5.5 billion raised by the 34 IPOs...read more

US IPO Weekly Recap: Year's hottest deal pops 186% in year's most active week with 13 IPOs

Things just got Seres in the IPO market. Thirteen companies went public this past week, more than any week since October 2014. Seres Therapeutics skyrocketed 186% on its debut - the highest first-day pop since January 2014. The thirteen IPOs raised $1.9 billion, less than expected because 70%...read more

High-growth device maker Glaukos prices IPO at $18, above the upwardly revised range

GKOS

Glaukos, which sells micro-scale surgical devices for treating glaucoma, raised $108 million by offering 6 million shares at $18, above the upwardly revised range of $16 to $17. The company had initially filed to offer 5.4 million shares at a range of $13-$15 before updating its terms on Tuesday. At its offer price, Glaukos commands a fully diluted market cap of $628 million. It...read more

Glaucoma gadget's got growth: Glaukos increases shares and range ahead of $100 million IPO

GKOS

Glaukos, which sells micro-scale surgical devices for treating glaucoma, raised the number of shares and increased the range ahead of its upcoming IPO on Tuesday. The Laguna Hills, CA-based company now plans to raise up to $102 million by offering 6.0 million shares at a price range of $16 to $17. The company had previously filed to offer 5.36 million shares at a range of $13...read more